9.	Earnings (Loss) and Dividends per Share

The computational components of basic and diluted earnings per share for the three-month and nine-month periods ended September 30, 2014 and 2013 are below.


	For the three-month period ended September 30, 2014
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic net income and earnings per share	$	3,703		25,692	$	0.14
Effect of dilutive securities and notes:
Common stock equivalents arising from stock options and employee stock purchase plan		—		437		—

Diluted earnings and earnings per share	$	3,703		26,129	$	0.14


	For the three-month period ended September 30, 2013
	Numerator (Income)			Denominator (Shares)		Per Share Amount
Basic net loss and loss per share	$	(1,461	)		19,965	$	(0.07	)
Effect of dilutive securities and notes:
Common stock equivalents arising from stock options and employee stock purchase plan		—			—		—

Diluted loss and loss per share	$	(1,461	)		19,965	$	(0.07	)


	For the nine-month period ended September 30, 2014
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic net income and earnings per share	$	11,217		25,647	$	0.44
Effect of dilutive securities and notes:
Common stock equivalents arising from stock options and employee stock purchase plan		—		458		(0.01	)

Diluted earnings and earnings per share	$	11,217		26,105	$	0.43


	For the nine-month period ended September 30, 2013
	Numerator (Income)		Denominator (Shares)		Per Share Amount
Basic net income and earnings per share	$	3,790		18,275	$	0.21
Effect of dilutive securities and notes:
Common stock equivalents arising from stock options and employee stock purchase plan		—		607		(0.01	)

Diluted earnings and earnings per share	$	3,790		18,882	$	0.20

Options and warrants included in the computation of diluted earnings per share are included using the treasury stock method. For each of the three-month and nine-month periods ended September 30, 2014, 150,000 outstanding options and warrants were excluded from the computation of diluted earnings per share due to their having an anti-dilutive effect. For each of the three-month and nine-month periods ended September 30, 2013, 40,000 outstanding options and warrants were excluded from the computation of diluted earnings per share due to their having an anti-dilutive effect.

Holders of certain restricted stock awards participate in nonforfeitable dividend rights on a one-for-one basis with holders of common stock. Holders of these awards are not obligated to share in losses of the Company. Therefore, these share awards are included in the computation of basic earnings per share during periods of net income using the two-class method, but are excluded from such computation in periods of net loss. Should the Company declare a dividend on its common stock, the related dividend on shares of unvested restricted stock that are not expected to vest would be recorded as additional compensation expense and therefore excluded from the two-class method computations. Undistributed earnings included in the two-class method computations are allocated equally to each share of common stock outstanding, including all shares of unvested restricted common shares.

Once a restricted stock award vests, it is included in the computation of weighted average shares outstanding for purposes of basic and diluted earnings per share.

The Company declared and on March 31, 2014 paid to common stockholders a quarterly dividend of $0.05 per share, declared and on June 27, 2014 paid to common stockholders a quarterly dividend of $0.06 per share, and declared and on September 30, 2014 paid to common stockholders a quarterly dividend of $0.06 per share. The dividend policy and the payment of cash dividends under that policy are subject to the Board of Directors’ continuing determination that the dividend policy and the declaration of dividends are in the best interest of the Company’s stockholders. Future dividends and the dividend policy may be changed or cancelled at the Company’s discretion at any time. Payment of dividends is also subject to the continuing consent of our lender under our Credit Facility.